Stocksigma LogoStocksigma Logo

Tarsons Products Q2FY27 Results: Strong Revenue Growth Offset by Margin Pressures

Tarsons Products reported a 20.8% YoY rise in consolidated Q2FY27 revenue to ₹123.7 cr, led by standalone domestic growth of 18.6% and export expansion of

Tarsons Products Q2FY27 Results: Strong Revenue Growth Offset by Margin Pressures

Tarsons Products Ltd · Investor Presentation · 13 Nov 2026, 5:49 am

Tarsons Products Q2FY27 Results: Strong Revenue Growth Offset by Margin Pressures Tarsons Products reported a 20.8% YoY rise in consolidated Q2FY27 revenue to ₹123.7 cr, led by standalone domestic growth of 18.6% and export expansion of 36.8%. However, higher raw material costs and expenses from newly commissioned facilities compressed consolidated EBITDA margins by 170 bps YoY to 25.1% (EBITDA at ₹31.1 cr). Elevated depreciation and finance charges resulted in a consolidated net loss of ₹0.3 cr versus a profit of ₹3.3 cr in Q2FY26. Commercial operations at Panchla's cell culture lines are slated for H2FY27.

Original exchange filing (PDF)

More announcements from Tarsons Products Ltd

All Tarsons Products Ltd announcements